http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10426783-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56541df79a26070c6c2c585b54af47c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4233c56d30f8bd8c826a2d8586bba5e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cd3ea6c52ef8544c67c051a2ef489b3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
filingDate 2016-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2555e277e45d6f1a16def16b18b44a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50cde188ae1f5e15541edafdabdb442f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea8c59472cfe80343ab440d0b3ee4a24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e5e4221f41bfc098c67ffa4a75eb63c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b162892fc156d12f739007a1f765822
publicationDate 2019-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-10426783-B2
titleOfInvention Therapeutic agent for ocular fundus disease
abstract Disclosed herein is a prophylactic or therapeutic agent for ocular fundus disease, especially diabetic retinopathy or age-related macular degeneration. The prophylactic or therapeutic agent for ocular fundus disease comprising: (S)-(−)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine, a salt thereof, or a solvate thereof, as an active ingredient.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017304199-A1
priorityDate 2013-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9920620-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006142270-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006068208-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0956865-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012012282-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004106646-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008194584-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006290827-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008519814-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H11349482-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013513664-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1818059-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012015760-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007084474-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02083175-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011144150-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011149012-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004106325-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6812
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393245
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226901923
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16219471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID688595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3821
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23676152
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66584305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID228404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406322

Total number of triples: 79.